Patient-Derived Cancer Organoids for Precision Oncology Treatment

The emergence of three-dimensional human organoids has opened the door for the development of patient-derived cancer organoid (PDO) models, which closely recapitulate parental tumor tissue. The mainstays of preclinical cancer modeling include in vitro cell lines and patient-derived xenografts, but t...

Descripción completa

Detalles Bibliográficos
Autores principales: Pernik, Mark N., Bird, Cylaina E., Traylor, Jeffrey I., Shi, Diana D., Richardson, Timothy E., McBrayer, Samuel K., Abdullah, Kalil G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156513/
https://www.ncbi.nlm.nih.gov/pubmed/34067714
http://dx.doi.org/10.3390/jpm11050423

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156513/
https://www.ncbi.nlm.nih.gov/pubmed/34067714
http://dx.doi.org/10.3390/jpm11050423

Ejemplares similares